A crossover study to evaluate the efficacy and safety of preprandial human insulin inhalation powder (HIIP) compared to preprandial injectable insulin in patients with type 1 diabetes mellitus
Phase of Trial: Phase II/III
Latest Information Update: 08 Oct 2014
At a glance
- Drugs Insulin; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2009 Actual patient number (70) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Actual end date (1 May 2008) added as reported by ClinicalTrials.gov.